rbg vector Search Results


vectors aav8 tbg pi cre rbg  (Addgene inc)
96
Addgene inc vectors aav8 tbg pi cre rbg
Vectors Aav8 Tbg Pi Cre Rbg, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rbg+vector/AAV%2ETBG%2EPI%2ECre%2ErBG+(Plasmid+%23107787)/pm41038273-44-46-51
Average 96 stars, based on 1 article reviews
vectors aav8 tbg pi cre rbg - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier
upenn vector core  (Addgene inc)
93
Addgene inc upenn vector core

Upenn Vector Core, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rbg+vector/pENN%2EAAV%2ECB7%2ECI%2EeGFP%2EWPRE%2ErBG+(Plasmid+%23105542)/pmc07080503-8-6-10
Average 93 stars, based on 1 article reviews
upenn vector core - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier
penn aav ctnt pi egfp wpre serotype 9 adenoviral vector  (Addgene inc)
93
Addgene inc penn aav ctnt pi egfp wpre serotype 9 adenoviral vector

Penn Aav Ctnt Pi Egfp Wpre Serotype 9 Adenoviral Vector, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rbg+vector/pENN%2EAAV%2EcTNT%2EPI%2EeGFP%2EWPRE%2ErBG+(Plasmid+%23105543)/bio_rxiv__2021__10__25__465773-273-28-33
Average 93 stars, based on 1 article reviews
penn aav ctnt pi egfp wpre serotype 9 adenoviral vector - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier
viral vectors aav1 camkii0 4 egfp wpre rbg  (Addgene inc)
90
Addgene inc viral vectors aav1 camkii0 4 egfp wpre rbg

Viral Vectors Aav1 Camkii0 4 Egfp Wpre Rbg, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rbg+vector/pGL4%2E23+C3_20+(Plasmid+%2360303)/pmc06807282-50-0-8
Average 90 stars, based on 1 article reviews
viral vectors aav1 camkii0 4 egfp wpre rbg - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier
aav9.cag.bip.vigf2.hgaaco.rbg.kanr (systemic; sys) vector  (Amicus Therapeutics)
90
Amicus Therapeutics aav9.cag.bip.vigf2.hgaaco.rbg.kanr (systemic; sys) vector
( A ) Experimental design: 3-month-old KO mice received a single injection of systemic vector (SYS; n = 5) at a dose of 2.5 × 10 13 vg/kg. <t>AAV9-based</t> liver-directed vector encoding untagged secretable hGAA served as a control (liver secreted, LS; n = 6). The samples were collected 1 month after dosing. ( B ) Western blot analysis of whole liver lysates with anti-human GAA antibody. Graphs show the amount and activity of the liver-expressed IGF2-tagged and untagged hGAA. ( C ) Western blot of plasma from SYS- and LS-treated KO mice. Ponceau stain was used to confirm equal protein loading. The amount of circulating precursor protein is quantified relative to a nonspecific band present in all samples. The amount and activity of the secreted hGAA are higher in LS- compared with SYS-treated KO mice. Statistical significance was determined by 1-way ANOVA and unpaired 2-tailed Student’s t test. Graphs represent mean ± SD. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001.
Aav9.Cag.Bip.Vigf2.Hgaaco.Rbg.Kanr (Systemic; Sys) Vector, supplied by Amicus Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rbg+vector/aav9+cln3/pmc10543735-31-15-19
Average 90 stars, based on 1 article reviews
aav9.cag.bip.vigf2.hgaaco.rbg.kanr (systemic; sys) vector - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier
viral vectors 159 aav1 camkii0 4 egfp wpre rbg  (Addgene inc)
90
Addgene inc viral vectors 159 aav1 camkii0 4 egfp wpre rbg
( A ) Experimental design: 3-month-old KO mice received a single injection of systemic vector (SYS; n = 5) at a dose of 2.5 × 10 13 vg/kg. <t>AAV9-based</t> liver-directed vector encoding untagged secretable hGAA served as a control (liver secreted, LS; n = 6). The samples were collected 1 month after dosing. ( B ) Western blot analysis of whole liver lysates with anti-human GAA antibody. Graphs show the amount and activity of the liver-expressed IGF2-tagged and untagged hGAA. ( C ) Western blot of plasma from SYS- and LS-treated KO mice. Ponceau stain was used to confirm equal protein loading. The amount of circulating precursor protein is quantified relative to a nonspecific band present in all samples. The amount and activity of the secreted hGAA are higher in LS- compared with SYS-treated KO mice. Statistical significance was determined by 1-way ANOVA and unpaired 2-tailed Student’s t test. Graphs represent mean ± SD. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001.
Viral Vectors 159 Aav1 Camkii0 4 Egfp Wpre Rbg, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rbg+vector/pD649-HAsp-TNFRSF4-COMP5AP-AviTag-9xHis+(Plasmid+%23157158)/10__1523_slash_jneurosci__1515___19__2019-37-2-10
Average 90 stars, based on 1 article reviews
viral vectors 159 aav1 camkii0 4 egfp wpre rbg - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier
penn aav cmvs turborfp wpre rbg  (Addgene inc)
91
Addgene inc penn aav cmvs turborfp wpre rbg
( A ) Experimental design: 3-month-old KO mice received a single injection of systemic vector (SYS; n = 5) at a dose of 2.5 × 10 13 vg/kg. <t>AAV9-based</t> liver-directed vector encoding untagged secretable hGAA served as a control (liver secreted, LS; n = 6). The samples were collected 1 month after dosing. ( B ) Western blot analysis of whole liver lysates with anti-human GAA antibody. Graphs show the amount and activity of the liver-expressed IGF2-tagged and untagged hGAA. ( C ) Western blot of plasma from SYS- and LS-treated KO mice. Ponceau stain was used to confirm equal protein loading. The amount of circulating precursor protein is quantified relative to a nonspecific band present in all samples. The amount and activity of the secreted hGAA are higher in LS- compared with SYS-treated KO mice. Statistical significance was determined by 1-way ANOVA and unpaired 2-tailed Student’s t test. Graphs represent mean ± SD. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001.
Penn Aav Cmvs Turborfp Wpre Rbg, supplied by Addgene inc, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rbg+vector/pENN%2EAAV%2ECMVs%2ETurboRFP%2EWPRE%2ERBG+(Plasmid+%23105548)/pmc10400289-46-16-24
Average 91 stars, based on 1 article reviews
penn aav cmvs turborfp wpre rbg - by Bioz Stars, 2026-11
91/100 stars
  Buy from Supplier
viral vector  (Addgene inc)
96
Addgene inc viral vector
( A ) Experimental design: 3-month-old KO mice received a single injection of systemic vector (SYS; n = 5) at a dose of 2.5 × 10 13 vg/kg. <t>AAV9-based</t> liver-directed vector encoding untagged secretable hGAA served as a control (liver secreted, LS; n = 6). The samples were collected 1 month after dosing. ( B ) Western blot analysis of whole liver lysates with anti-human GAA antibody. Graphs show the amount and activity of the liver-expressed IGF2-tagged and untagged hGAA. ( C ) Western blot of plasma from SYS- and LS-treated KO mice. Ponceau stain was used to confirm equal protein loading. The amount of circulating precursor protein is quantified relative to a nonspecific band present in all samples. The amount and activity of the secreted hGAA are higher in LS- compared with SYS-treated KO mice. Statistical significance was determined by 1-way ANOVA and unpaired 2-tailed Student’s t test. Graphs represent mean ± SD. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001.
Viral Vector, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rbg+vector/pcDNA3%2E1(%2B)+Laccase2+MCS+Exon+Vector+(Plasmid+%2369893)/pmc07757562-207-14-17
Average 96 stars, based on 1 article reviews
viral vector - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier
aav-cre (aav8.tbg.pi.cre.rbg)  (BioCore Inc)
90
BioCore Inc aav-cre (aav8.tbg.pi.cre.rbg)
( A ) Experimental design: 3-month-old KO mice received a single injection of systemic vector (SYS; n = 5) at a dose of 2.5 × 10 13 vg/kg. <t>AAV9-based</t> liver-directed vector encoding untagged secretable hGAA served as a control (liver secreted, LS; n = 6). The samples were collected 1 month after dosing. ( B ) Western blot analysis of whole liver lysates with anti-human GAA antibody. Graphs show the amount and activity of the liver-expressed IGF2-tagged and untagged hGAA. ( C ) Western blot of plasma from SYS- and LS-treated KO mice. Ponceau stain was used to confirm equal protein loading. The amount of circulating precursor protein is quantified relative to a nonspecific band present in all samples. The amount and activity of the secreted hGAA are higher in LS- compared with SYS-treated KO mice. Statistical significance was determined by 1-way ANOVA and unpaired 2-tailed Student’s t test. Graphs represent mean ± SD. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001.
Aav Cre (Aav8.Tbg.Pi.Cre.Rbg), supplied by BioCore Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rbg+vector/aav8+tbg+pi+egfp+wpre+bgh/pm37245295-61-0-14
Average 90 stars, based on 1 article reviews
aav-cre (aav8.tbg.pi.cre.rbg) - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier
penn aav cb7 ci pm20d1flag wpre rbg vector  (Addgene inc)
93
Addgene inc penn aav cb7 ci pm20d1flag wpre rbg vector
( A ) Experimental design: 3-month-old KO mice received a single injection of systemic vector (SYS; n = 5) at a dose of 2.5 × 10 13 vg/kg. <t>AAV9-based</t> liver-directed vector encoding untagged secretable hGAA served as a control (liver secreted, LS; n = 6). The samples were collected 1 month after dosing. ( B ) Western blot analysis of whole liver lysates with anti-human GAA antibody. Graphs show the amount and activity of the liver-expressed IGF2-tagged and untagged hGAA. ( C ) Western blot of plasma from SYS- and LS-treated KO mice. Ponceau stain was used to confirm equal protein loading. The amount of circulating precursor protein is quantified relative to a nonspecific band present in all samples. The amount and activity of the secreted hGAA are higher in LS- compared with SYS-treated KO mice. Statistical significance was determined by 1-way ANOVA and unpaired 2-tailed Student’s t test. Graphs represent mean ± SD. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001.
Penn Aav Cb7 Ci Pm20d1flag Wpre Rbg Vector, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rbg+vector/pENN%2EAAV%2ECB7%2ECI%2EPM20D1-flag%2EWPRE%2ErBG+(Plasmid+%23132682)/pmc11045224-326-25-27
Average 93 stars, based on 1 article reviews
penn aav cb7 ci pm20d1flag wpre rbg vector - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier
cre recombinase  (Addgene inc)
96
Addgene inc cre recombinase
( A ) Experimental design: 3-month-old KO mice received a single injection of systemic vector (SYS; n = 5) at a dose of 2.5 × 10 13 vg/kg. <t>AAV9-based</t> liver-directed vector encoding untagged secretable hGAA served as a control (liver secreted, LS; n = 6). The samples were collected 1 month after dosing. ( B ) Western blot analysis of whole liver lysates with anti-human GAA antibody. Graphs show the amount and activity of the liver-expressed IGF2-tagged and untagged hGAA. ( C ) Western blot of plasma from SYS- and LS-treated KO mice. Ponceau stain was used to confirm equal protein loading. The amount of circulating precursor protein is quantified relative to a nonspecific band present in all samples. The amount and activity of the secreted hGAA are higher in LS- compared with SYS-treated KO mice. Statistical significance was determined by 1-way ANOVA and unpaired 2-tailed Student’s t test. Graphs represent mean ± SD. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001.
Cre Recombinase, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rbg+vector/CRE+recombinase+(Plasmid+%2362730)/pm37610219-36-37-46
Average 96 stars, based on 1 article reviews
cre recombinase - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier
penn aav camkii0 4  (Addgene inc)
93
Addgene inc penn aav camkii0 4
( A ) Experimental design: 3-month-old KO mice received a single injection of systemic vector (SYS; n = 5) at a dose of 2.5 × 10 13 vg/kg. <t>AAV9-based</t> liver-directed vector encoding untagged secretable hGAA served as a control (liver secreted, LS; n = 6). The samples were collected 1 month after dosing. ( B ) Western blot analysis of whole liver lysates with anti-human GAA antibody. Graphs show the amount and activity of the liver-expressed IGF2-tagged and untagged hGAA. ( C ) Western blot of plasma from SYS- and LS-treated KO mice. Ponceau stain was used to confirm equal protein loading. The amount of circulating precursor protein is quantified relative to a nonspecific band present in all samples. The amount and activity of the secreted hGAA are higher in LS- compared with SYS-treated KO mice. Statistical significance was determined by 1-way ANOVA and unpaired 2-tailed Student’s t test. Graphs represent mean ± SD. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001.
Penn Aav Camkii0 4, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rbg+vector/pENN%2EAAV%2ECamKII0%2E4%2EeGFP%2EWPRE%2ErBG+(Plasmid+%23105541)/bio_rxiv__2022__11__11__516100-269-18-15
Average 93 stars, based on 1 article reviews
penn aav camkii0 4 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

Image Search Results


Journal: eLife

Article Title: Contextual and cross-modality modulation of auditory cortical processing through pulvinar mediated suppression

doi: 10.7554/eLife.54157

Figure Lengend Snippet:

Article Snippet: Recombinant DNA reagent , AAV2/1-CB7-Cl-eGFP-WPRE-rBG , UPenn Vector Core , Addgene #105542 , .

Techniques: Recombinant, Plasmid Preparation, Staining, Software

( A ) Experimental design: 3-month-old KO mice received a single injection of systemic vector (SYS; n = 5) at a dose of 2.5 × 10 13 vg/kg. AAV9-based liver-directed vector encoding untagged secretable hGAA served as a control (liver secreted, LS; n = 6). The samples were collected 1 month after dosing. ( B ) Western blot analysis of whole liver lysates with anti-human GAA antibody. Graphs show the amount and activity of the liver-expressed IGF2-tagged and untagged hGAA. ( C ) Western blot of plasma from SYS- and LS-treated KO mice. Ponceau stain was used to confirm equal protein loading. The amount of circulating precursor protein is quantified relative to a nonspecific band present in all samples. The amount and activity of the secreted hGAA are higher in LS- compared with SYS-treated KO mice. Statistical significance was determined by 1-way ANOVA and unpaired 2-tailed Student’s t test. Graphs represent mean ± SD. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001.

Journal: JCI Insight

Article Title: AAV-mediated delivery of secreted acid α -glucosidase with enhanced uptake corrects neuromuscular pathology in Pompe mice

doi: 10.1172/jci.insight.170199

Figure Lengend Snippet: ( A ) Experimental design: 3-month-old KO mice received a single injection of systemic vector (SYS; n = 5) at a dose of 2.5 × 10 13 vg/kg. AAV9-based liver-directed vector encoding untagged secretable hGAA served as a control (liver secreted, LS; n = 6). The samples were collected 1 month after dosing. ( B ) Western blot analysis of whole liver lysates with anti-human GAA antibody. Graphs show the amount and activity of the liver-expressed IGF2-tagged and untagged hGAA. ( C ) Western blot of plasma from SYS- and LS-treated KO mice. Ponceau stain was used to confirm equal protein loading. The amount of circulating precursor protein is quantified relative to a nonspecific band present in all samples. The amount and activity of the secreted hGAA are higher in LS- compared with SYS-treated KO mice. Statistical significance was determined by 1-way ANOVA and unpaired 2-tailed Student’s t test. Graphs represent mean ± SD. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001.

Article Snippet: In vivo efficacy of AAV9-mediated gene transfer was evaluated following a single intravenous administration of AAV9.CAG.BiP.vIGF2.hGAAco.rBG.KanR (systemic; SYS) vector (Amicus proprietary) into young (3–3.5 months of age) or old (8–9 months of age) Gaa -KO mice (referred to as KO), a model of Pompe disease ( ).

Techniques: Injection, Plasmid Preparation, Western Blot, Activity Assay, Staining